Published in Pharm Res on September 01, 2000
Effects of physical properties for starch acetate powders on tableting. AAPS PharmSciTech (2002) 1.29
New direct compression excipient from tigernut starch: physicochemical and functional properties. AAPS PharmSciTech (2013) 0.75
Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation (1995) 1.76
Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol (2001) 1.37
Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol (2004) 1.31
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant (2000) 1.25
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant (2007) 1.12
Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol (1997) 1.09
Characterization of human type III collagen expressed in a baculovirus system. Production of a protein with a stable triple helix requires coexpression with the two types of recombinant prolyl 4-hydroxylase subunit. J Biol Chem (1996) 1.04
A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene (2011) 1.01
Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. Biochim Biophys Acta (1996) 0.98
Time-dependent densification behaviour of cyclodextrins. J Pharm Pharmacol (1996) 0.98
Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation (1994) 0.97
Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis. Br J Dermatol (2003) 0.95
Optical inspection of punches: flat surfaces. Eur J Pharm Biopharm (2000) 0.93
Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Histochem Cell Biol (2001) 0.92
Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb (1993) 0.91
A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma. Respiration (1998) 0.87
Adaptation to myocardial ischemia during repeated dynamic exercise in relation to findings at cardiac catheterization. Am Heart J (1996) 0.85
Dynamic solid-state and tableting properties of four theophylline forms. Int J Pharm (2001) 0.85
Keratinocytes cultured from patients with Hailey-Hailey disease and Darier disease display distinct patterns of calcium regulation. Br J Dermatol (2005) 0.85
A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal doses. Ann Allergy (1994) 0.84
Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. Lab Invest (1995) 0.84
Pulmonary deposition of lactose carriers used in inhalation powders. Int J Pharm (2000) 0.84
In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy. Acta Pharm Nord (1990) 0.83
Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation. Eur J Pharm Sci (2000) 0.82
Compressional characteristics of four starches. J Pharm Pharmacol (1983) 0.82
Predicting plasticization efficiency from three-dimensional molecular structure of a polymer plasticizer. Pharm Res (2001) 0.82
Clinical features of patients with a serum M component. Acta Med Scand (1978) 0.82
New function for NF1 tumor suppressor. J Invest Dermatol (2000) 0.82
Expression profiles of cell-cell and cell-matrix junction proteins in developing human epidermis. Arch Dermatol Res (2001) 0.82
Bioavailability of doxycycline from dissolved doxycycline hydrochloride tablets--comparison to solid form hydrochloride tablets and dissolved monohydrate tablets. Int J Clin Pharmacol Ther Toxicol (1990) 0.82
Pharmacokinetics in rat of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a drinking water mutagen, after a single dose. Pharmacol Toxicol (1992) 0.81
Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use. Respiration (1994) 0.81
Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations. Int J Clin Pharmacol Ther Toxicol (1990) 0.81
Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase. Biomaterials (2004) 0.81
Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin. Pharm Res (1991) 0.79
Frictional work in double-sided tablet compression. J Pharm Sci (1997) 0.79
Drug release from pH and ionic strength responsive poly(acrylic acid) grafted poly(vinylidenefluoride) membrane bags in vitro. Pharm Res (1998) 0.78
Normothermic versus mild hypothermic retrograde blood cardioplegia: a prospective, randomized study. Ann Thorac Surg (1995) 0.78
Adsorption of drugs onto a poly(acrylic acid) grafted cation-exchange membrane. Eur J Pharm Sci (1999) 0.78
Peripheral arterial disease as a predictor of outcome after renal transplantation. Transpl Int (1998) 0.77
Physical properties and clinical efficacy of two sodium cromoglycate inhalation aerosol preparations. Acta Pharm Nord (1991) 0.77
Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacol Toxicol (1992) 0.76
The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab Dispos (1990) 0.76
Effect of the new spacer-device on the deposition of the inhaled metered dose aerosol. Pharmazie (1990) 0.76
Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin. Int J Pharm (2001) 0.76
In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols. Pharmazie (1991) 0.76
Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand (2002) 0.75
Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests. Eur J Pharm Sci (2000) 0.75
Dose of inhaled beta 2-agonists in asthma. Lancet (1991) 0.75
Evaluation of a novel cellulose powder as a filler-binder for direct compression of tablets. Pharm Weekbl Sci (1989) 0.75
Changes in solid-state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage. Pharm Res (1995) 0.75
Dynamic laser speckle pattern in monitoring of local deformation of tablet surface after compression. Int J Pharm (2000) 0.75
In vitro deposition and clinical efficacy of two sodium cromoglycate inhalation powders. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies. Pharm Res (1994) 0.75
Thermophysical properties of some pharmaceutical excipients compressed in tablets. Pharm Res (1995) 0.75
Influence of ionic strength on drug adsorption onto and release from a poly(acrylic acid) grafted poly(vinylidene fluoride) membrane. Int J Pharm (1999) 0.75
Effects of inspirease holding chamber on the deposition of metered dose inhalation aerosols. Eur J Drug Metab Pharmacokinet (1991) 0.75
Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions. Pharm Res (2000) 0.75
Comparison of two beclomethasone dipropionate inhalation aerosol spacer combinations in the treatment of asthma. Int J Clin Pharmacol Ther (1994) 0.75
Removal of inhaled 99mTc-labelled particles of disodium cromoglycate from the lungs. Acta Pharm Nord (1991) 0.75
Transport of drugs across porous ion exchange membranes. J Control Release (1998) 0.75
Effect of central muscle relaxants on single-dose pharmacokinetics of peroral paracetamol in man. Int J Clin Pharmacol Ther Toxicol (1990) 0.75
Microencapsulation of indomethacin by gelatin-acacia complex coacervation in the presence of surfactants. J Microencapsul (1995) 0.75
Ultrastructural localization of NF1 tumor suppressor protein in human skin. Arch Dermatol Res (2002) 0.75
Nasal distribution of radioactive drug administered using two dosage forms. Eur J Drug Metab Pharmacokinet (1991) 0.75
Xylan--a possible filler and disintegrant for tablets. J Pharm Pharmacol (1984) 0.75
Drug release from cation exchange membrane in rabbit eye. J Ocul Pharmacol Ther (1999) 0.75
Deposition and gastrointestinal transit of conventional sucralfate tablets. Acta Pharm Nord (1991) 0.75
Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
Electrochemical characterization of human skin by impedance spectroscopy: the effect of penetration enhancers. Pharm Res (1993) 0.75
IgE-binding components of cultured human keratinocytes in atopic eczema/dermatitis syndrome and their crossreactivity with Malassezia furfur. Allergy (2004) 0.75
Drug release from a porous ion-exchange membrane in vitro. Biomaterials (1999) 0.75
Haemodynamic results of femoropopliteal percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg (1998) 0.75
Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules. Int J Clin Pharmacol Res (1989) 0.75
Optical surface roughness study of starch acetate compacts. Int J Pharm (1999) 0.75
Drug release from poly(acrylic acid) grafted poly(vinylidene fluoride) membrane bags in the gastrointestinal tract in the rat and dog. J Control Release (2000) 0.75